microRNA-483 Protects Pancreatic β-Cells by Targeting ALDH1A3.

Zhihong Wang, Ramkumar Mohan, Xinqian Chen, Katy Matson, Jackson Waugh, Yiping Mao, Shungang Zhang, Wanzhen Li, Xiaohu Tang, Leslie S Satin, Xiaoqing Tang

Endocrinology 2021 May 01

filter terms:

Pancreatic β-cell dysfunction is central to the development and progression of type 2 diabetes. Dysregulation of microRNAs (miRNAs) has been associated with pancreatic islet dysfunction in type 2 diabetes. Previous study has shown that miR-483 is expressed relatively higher in β-cells than in α-cells. To explore the physiological function of miR-483, we generated a β-cell-specific knockout mouse model of miR-483. Loss of miR-483 enhances high-fat diet-induced hyperglycemia and glucose intolerance by the attenuation of diet-induced insulin release. Intriguingly, mice with miR-483 deletion exhibited loss of β-cell features, as indicated by elevated expression of aldehyde dehydrogenase family 1, subfamily A3 (Aldh1a3), a marker of β-cell dedifferentiation. Moreover, Aldh1a3 was validated as a direct target of miR-483 and overexpression of miR-483 repressed Aldh1a3 expression. Genetic ablation of miR-483 also induced alterations in blood lipid profile. Collectively, these data suggest that miR-483 is critical in protecting β-cell function by repressing the β-cell disallowed gene Aldh1a3. The dysregulated miR-483 may impair insulin secretion and initiate β-cell dedifferentiation during the development of type 2 diabetes. Published by Oxford University Press on behalf of the Endocrine Society 2021.

Citation

Zhihong Wang, Ramkumar Mohan, Xinqian Chen, Katy Matson, Jackson Waugh, Yiping Mao, Shungang Zhang, Wanzhen Li, Xiaohu Tang, Leslie S Satin, Xiaoqing Tang. microRNA-483 Protects Pancreatic β-Cells by Targeting ALDH1A3. Endocrinology. 2021 May 01;162(5)